TheraRadar
← Back
Data updated: Mar 29, 2026

PADAGIS ISRAEL

DermatologyImmunologyNeurology
Generics

PADAGIS ISRAEL is a generic drug manufacturer focused on Dermatology, Immunology, Neurology.

2000
Since
49
Drugs
-
Trials
336
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 38%
5 drugs
Immunology 23%
3 drugs
Neurology 15%
2 drugs
Oncology 15%
2 drugs
Gastroenterology 8%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...